Over a month ago | ||||
Barclays analyst Kanad… Barclays analyst Kanad Mitra lowered the firm's price target on Primary Health Properties to 140 GBp from 160 GBp and keeps an Overweight rating on the shares. |
Over a quarter ago | ||||
Stifel analyst John… Stifel analyst John Cahill downgraded Primary Health Properties to Hold from Buy with an unchanged price target of 155 GBp. Shares have risen 12% since the February low and while he sees "very good reasons" for the shares to maintain a premium rating, he thinks shares offer fair value around the current level, Cahill tells investors. |